AstraZeneca pursued acquisition of Forest Laboratories, sources say, before the specialty-drug company agreed last week to be bought by Actavis PLC for $25 billion.
from WSJ.com: US Business http://ift.tt/1kc4IU8
via IFTTT
from WSJ.com: US Business http://ift.tt/1kc4IU8
via IFTTT
No comments:
Post a Comment